LONDON (UK) – Britain’s Prince William on Wednesday visited the Oxford-based scientists who are working to develop a potential vaccine for COVID-19 as well as trial participants who are helping to determine whether or not the shots work.
Originally known as ChAdOx1 nCoV-19, the shot was developed by scientists at the University of Oxford, and they are now working with AstraZeneca on development and production.
The vaccine is already in human trials, with preliminary trials on pigs and monkeys showing some encouraging signs for the experimental vaccine, which is also known as AZD1222.
Queen Elizabeth’s grandson and second-in-line to the throne Prince Wiliam met researchers, including the vaccine’s developer Sarah Gilbert and the leader of the clinical trial team Andrew Pollard.
He also met AstraZeneca Chief Executive Pascal Soriot, and officials from Coalition for Epidemic Preparedness Innovations (CEPI) and international vaccine alliance Gavi via a video call.
AstraZeneca has inked agreements with Britain, the United States and European countries to supply the vaccine.
Soriot has said that trial clinical results are expected in August or September, with deliveries possible from October.
(Photos syndicated via Reuters)
This story has been edited by BH staff and is published from a syndicated field